Transdifferentiation and Proliferation in Two Distinct Hemocyte Lineages in Drosophila melanogaster Larvae after Wasp Infection

PLoS Pathog. 2016 Jul 14;12(7):e1005746. doi: 10.1371/journal.ppat.1005746. eCollection 2016 Jul.

Abstract

Cellular immune responses require the generation and recruitment of diverse blood cell types that recognize and kill pathogens. In Drosophila melanogaster larvae, immune-inducible lamellocytes participate in recognizing and killing parasitoid wasp eggs. However, the sequence of events required for lamellocyte generation remains controversial. To study the cellular immune system, we developed a flow cytometry approach using in vivo reporters for lamellocytes as well as for plasmatocytes, the main hemocyte type in healthy larvae. We found that two different blood cell lineages, the plasmatocyte and lamellocyte lineages, contribute to the generation of lamellocytes in a demand-adapted hematopoietic process. Plasmatocytes transdifferentiate into lamellocyte-like cells in situ directly on the wasp egg. In parallel, a novel population of infection-induced cells, which we named lamelloblasts, appears in the circulation. Lamelloblasts proliferate vigorously and develop into the major class of circulating lamellocytes. Our data indicate that lamellocyte differentiation upon wasp parasitism is a plastic and dynamic process. Flow cytometry with in vivo hemocyte reporters can be used to study this phenomenon in detail.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Lineage
  • Cell Proliferation*
  • Cell Transdifferentiation / physiology*
  • Drosophila melanogaster / parasitology*
  • Drosophila melanogaster / physiology*
  • Flow Cytometry / methods
  • Hematopoiesis / physiology*
  • Hemocytes / cytology*
  • Immunohistochemistry
  • Larva
  • Microscopy, Confocal
  • Wasps*

Grants and funding

This work was supported by the Swedish Research Council and the Swedish Cancer Society (DH), the Academy of Finland (DH, LV, MR, TOI), the Sigrid Juselius Foundation (DH, MR), the Tampere Tuberculosis Foundation (MR), Competitive State Research Financing of the Tampere University Hospital (MR), Competitive State Research Financing of the Oulu University Hospital (MR), and the Hungarian Science Foundation (IAndó). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.